Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- In PCOS, unclear CV risk burden presents challenge for clinicians
-
- FDA committee narrowly supports continued CV outcomes trials for diabetes drugs
- Bariatric surgery can halve risk for CV events in type 2 diabetes
- Depression may cause nonclassical hypogonadism
- Long-term GH blocker safe, effective in acromegaly
- No association between long-term GH replacement, comorbidities in nonfunctioning pituitary adenoma
- Risk for additional autoimmune diseases substantial for women, white adults with type 1 diabetes
- Undiagnosed prediabetes common among men with primary infertility
- Vitamin D deficiency may increase breast cancer risk in postmenopausal women
-
- Bariatric embolization targets ghrelin for weight loss
- BMD trajectory can replace fracture as outcome in osteoporosis clinical trials
- GLP-1 receptor agonists may be 'critical' weight-loss tool in severe pediatric obesity
- Gestational diabetes insulin protocol following betamethasone reduces neonatal hypoglycemia
- Obesity comorbidities more likely to resolve after bariatric surgery for teens vs. adults
- Obesity drives risk for heart disease, requires collaboration
- Recent obesity trials demonstrate CV, diabetes benefits with weight loss
- Risk for second fracture within 1 year nearly double in men vs. women
-
- ‘Viral endocrinology’ an emerging field in insulin research
- Do women with PCOS and an atherosclerotic CVD risk greater than 5% benefit from statin therapy?